NCT00375570View on ClinicalTrials.gov

Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Herpes Labialis
Interventions
DRUG

ME-609

Topical treatment 5 times daily for 5 days

Sponsors

Lead Sponsor

Medivir
All Listed Sponsors
lead

Medivir

INDUSTRY

NCT00375570 - Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents | Biotech Hunter | Biotech Hunter